Article
Cdkn2a, the cyclin-dependent kinase inhibitor encoding p16INK4a and p19ARF, is a candidate for the plasmacytoma susceptibility locus, Pctr1.
Proceedings of the National Academy of Sciences of the United States of America - 3 Mar 1998
Zhang S, Ramsay E S, Mock B A
Abstract excerpt
Plasma cell tumor induction in mice by pristane is under multigenic control. BALB/c mice are susceptible to tumor development; whereas DBA/2 mice are resistant. Restriction fragment length polymorphisms between BALB/c and DBA/2 for Cdkn2a(p16) and Cdkn2b(p15), and between BALB/c and Mus spretus f...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
